Blood test study for early liver cancer detection
Part of Cancer, Digestive system clinical trials.
This study tests a new blood test (called Seravue) to see if it can help find liver cancer early in people who are at higher risk. If you have liver cirrhosis or hepatitis B, you may be able to join and help improve how liver cancer is detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 84 years old.
- You have been diagnosed with liver cirrhosis (from any cause) or with hepatitis B (with or without cirrhosis).
- You are willing to give blood samples and have regular liver ultrasounds and blood tests (AFP) as part of your standard care.
- You have not had liver cancer before or any cancer that has spread.
- You are not currently pregnant or planning to become pregnant during the study.
- You are not on the liver transplant waiting list.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This trial is testing if a blood test can find liver cancer early. It may help people who are newly diagnosed or suspected to have liver cancer and have not started treatment yet.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
This study tests whether adding a simple blood test (GAAD score) to a routine liver ultrasound can find early-stage liver cancer sooner in people with chronic liver conditions. It aims to improve detection in Asian populations at risk.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
Hear when a new Hepatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.